BR0214241A - Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida - Google Patents

Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida

Info

Publication number
BR0214241A
BR0214241A BR0214241-4A BR0214241A BR0214241A BR 0214241 A BR0214241 A BR 0214241A BR 0214241 A BR0214241 A BR 0214241A BR 0214241 A BR0214241 A BR 0214241A
Authority
BR
Brazil
Prior art keywords
composition
preparing
lidocaine
containing liposomes
topical anesthetic
Prior art date
Application number
BR0214241-4A
Other languages
English (en)
Inventor
Pravin M Patel
Original Assignee
Ferndale Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferndale Lab Inc filed Critical Ferndale Lab Inc
Publication of BR0214241A publication Critical patent/BR0214241A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"MéTODO PARA PREPARAR UMA COMPOSIçãO COMPREENDENDO LIPOSSOMAS CONTENDO ANESTéSICO TóPICO E COMPOSIçãO OBTIDA". Composição compreendendo lipossomas contendo lidocaína, sendo que a concentração em peso de lidocaína em dita composição é superior a 10%. A composição é preparada misturando-se água com uma fase oleosa compreendendo lidocaína, um álcoól C~ 14~-C~ 20~, um alquil éster de um ácido graxo, propileno glicol, e um estearato de polialquila. A fase não aquosa pode também incluir um fosfolipídeo tal como fosfatidil colina.
BR0214241-4A 2001-11-13 2002-11-13 Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida BR0214241A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33813201P 2001-11-13 2001-11-13
US10/290,983 US7476400B2 (en) 2001-11-13 2002-11-08 High-concentration lidocaine compositions and methods for their preparation
PCT/US2002/036349 WO2003041648A2 (en) 2001-11-13 2002-11-13 High-concentration lidocaine compositions and methods for their preparation

Publications (1)

Publication Number Publication Date
BR0214241A true BR0214241A (pt) 2004-12-21

Family

ID=26966511

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214241-4A BR0214241A (pt) 2001-11-13 2002-11-13 Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida

Country Status (8)

Country Link
US (1) US7476400B2 (pt)
EP (1) EP1453483A2 (pt)
JP (1) JP2005508994A (pt)
BR (1) BR0214241A (pt)
CA (1) CA2467167A1 (pt)
MX (1) MXPA04004570A (pt)
NZ (1) NZ533451A (pt)
WO (1) WO2003041648A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007261984A (ja) * 2006-03-28 2007-10-11 Konica Minolta Medical & Graphic Inc 脂肪酸エステルを有するリポソ−ムおよびその製剤
AU2007299608A1 (en) * 2006-09-21 2008-03-27 Coastal Solutions, Inc. Compositions and methods for treating jellyfish stings
JP5472756B2 (ja) 2008-10-02 2014-04-16 マイラン・インク 多層接着ラミネートの作製方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
US10265283B2 (en) * 2012-12-07 2019-04-23 Sambria Pharmaceuticals, Llc Topical composition and delivery system and its use
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
WO2023137405A2 (en) * 2022-01-13 2023-07-20 The Research Foundation For The State University Of New York Ultraflexible liposomes in gel formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (pt) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4721612A (en) 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
CA2150463A1 (en) * 1992-12-02 1994-06-09 Donald F. H. Wallach Extended duration antacid product
JP4467789B2 (ja) 1997-09-18 2010-05-26 パシラ ファーマシューティカルズ インコーポレーテッド 持続放出性リポソーム麻酔組成物

Also Published As

Publication number Publication date
MXPA04004570A (es) 2005-03-07
US7476400B2 (en) 2009-01-13
CA2467167A1 (en) 2003-05-22
WO2003041648A2 (en) 2003-05-22
JP2005508994A (ja) 2005-04-07
NZ533451A (en) 2006-01-27
WO2003041648A3 (en) 2003-11-13
US20030104046A1 (en) 2003-06-05
EP1453483A2 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
ES2183869T3 (es) Emulsiones de aceite en agua que contienen propofol y edetato.
BR0111532A (pt) Composições de éteres de monoalquila de glicerol de armazenamento estável
EP0331489B1 (en) Acne treatment
PE20130216A1 (es) Formulacion topica para un inhibidor de jak
BR0214241A (pt) Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida
AR052750A1 (es) Reductores de viscosidad para emulsiones inversas
KR20000053244A (ko) 피부질환의 치료방법
EP0164716B1 (en) Stabilized clear benzoyl peroxide compositions
BRPI0014869B8 (pt) prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
US5219880A (en) Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
ES2523873T3 (es) Administración de un inhibidor parcial de la oxidación de ácidos grasos, tal como ranolazina, para el tratamiento de la diabetes
BRPI0401642A (pt) Composição umectante para a pele
BR0013385A (pt) Composições farmacêuticas para administração oral e tópica
JPS5665809A (en) Toiletry
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
DE50210655D1 (de) Stabilisierung kosmetischer oder dermatologischer zubereitungen, welche repellent-wirkstoffe enthalten
WO2008143090A1 (ja) 油中水型乳化組成物
JP2023041793A5 (pt)
BR0104390A (pt) Método para redução de inflamação e eritema
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
BR112022022281A2 (pt) Misturas e composições compreendendo 5-fluoro-4-imino-3-metil- 1-tosil-3,4-dihidropirimidin-2-ona e métodos de uso das mesmas
AR063894A1 (es) Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica
BR0013518A (pt) Composição antiperspirante anìdrica e processo para controlar mau cheiro associado com transpiração
BRPI0406394A (pt) Método e composição para redução do crescimento do pêlo, método de fabricação de uma emulsão de óleo em água, composição de inibição do crescimento de pêlo tópica, e, uso de uma emulsão

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.